JPMorgan Chase & Co. Acquires 52,019 Shares of Medical Properties Trust Inc. (MPW)
JPMorgan Chase & Co. raised its position in Medical Properties Trust Inc. (NYSE:MPW) by 31.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 217,820 shares of the real estate investment trust’s stock after buying an additional 52,019 shares during the period. JPMorgan Chase & Co. owned 0.09% of Medical Properties Trust worth $3,313,000 at the end of the most recent reporting period.
A number of other institutional investors have also added to or reduced their stakes in the company. LSV Asset Management raised its position in Medical Properties Trust by 384.9% in the second quarter. LSV Asset Management now owns 1,709,276 shares of the real estate investment trust’s stock worth $25,998,000 after buying an additional 1,356,800 shares in the last quarter. Emerald Acquisition Ltd. acquired a new position in Medical Properties Trust during the second quarter worth approximately $14,420,000. Rothschild Asset Management Inc. acquired a new position in Medical Properties Trust during the second quarter worth approximately $12,679,000. Foundry Partners LLC acquired a new position in Medical Properties Trust during the second quarter worth approximately $12,496,000. Finally, Hillcrest Asset Management LLC acquired a new position in Medical Properties Trust during the first quarter worth approximately $7,071,000. 61.85% of the stock is currently owned by institutional investors and hedge funds.
Shares of Medical Properties Trust Inc. (NYSE:MPW) opened at 14.65 on Wednesday. The company’s 50-day moving average is $14.60 and its 200 day moving average is $14.63. Medical Properties Trust Inc. has a 52-week low of $9.61 and a 52-week high of $15.92. The firm has a market capitalization of $3.49 billion, a P/E ratio of 17.91 and a beta of 0.93.
Medical Properties Trust (NYSE:MPW) last announced its quarterly earnings data on Thursday, August 4th. The real estate investment trust reported $0.32 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.32. Medical Properties Trust had a return on equity of 9.06% and a net margin of 38.03%. The business had revenue of $126.30 million for the quarter, compared to analysts’ expectations of $128.04 million. During the same period in the previous year, the business posted $0.30 EPS. The firm’s quarterly revenue was up 26.6% compared to the same quarter last year. Analysts expect that Medical Properties Trust Inc. will post $1.27 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 13th. Investors of record on Thursday, September 15th were paid a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a yield of 6.26%. The ex-dividend date was Tuesday, September 13th. Medical Properties Trust’s dividend payout ratio is currently 115.00%.
MPW has been the topic of a number of analyst reports. TheStreet upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a research note on Tuesday, June 21st. JMP Securities downgraded shares of Medical Properties Trust from an “outperform” rating to a “market perform” rating in a research note on Friday, July 1st. Zacks Investment Research downgraded shares of Medical Properties Trust from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 19th. Deutsche Bank AG initiated coverage on shares of Medical Properties Trust in a research note on Friday, July 22nd. They set a “buy” rating and a $17.00 price objective on the stock. Finally, BTIG Research initiated coverage on shares of Medical Properties Trust in a research note on Thursday, August 25th. They set a “neutral” rating on the stock. Six analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $14.17.
In related news, Director G Steven Dawson sold 10,000 shares of the business’s stock in a transaction dated Friday, August 19th. The stock was sold at an average price of $15.36, for a total value of $153,600.00. Following the sale, the director now directly owns 67,729 shares in the company, valued at approximately $1,040,317.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman Edward K. Aldag, Jr. sold 50,000 shares of the business’s stock in a transaction dated Tuesday, August 9th. The shares were sold at an average price of $15.52, for a total value of $776,000.00. Following the completion of the sale, the chairman now owns 1,927,313 shares in the company, valued at $29,911,897.76. The disclosure for this sale can be found here. 1.44% of the stock is owned by corporate insiders.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust (REIT) focused on investing in and owning net-leased healthcare facilities. It conducts all of its business through MPT Operating Partnership, L.P. It acquires and develops healthcare facilities and leases the facilities to healthcare operating companies under long-term net leases.
Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust Inc. (NYSE:MPW).
Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.